Chugai Pharmaceutical (CHGCY) Insider Trading & Ownership $25.83 -0.70 (-2.64%) As of 05/28/2025 03:59 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisChartEarningsHeadlinesInsider TradesSEC FilingsShort InterestBuy This Stock There is no recent insider trading on record for Chugai Pharmaceutical, but the stock has been recently traded by U.S. Congress members, who may have more information about the industry than the general public. Get CHGCY Insider Trade Alerts Want to know when executives and insiders are buying or selling Chugai Pharmaceutical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Chugai Pharmaceutical Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellAverage Share PriceTotal Transaction4/9/2025Josh GottheimerU.S. Congress Member (D-NJ)Sell$22.94$1,001 - $15,0006/21/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$16.06$1,001 - $15,0004/4/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$18.15$1,001 - $15,0008/18/2023Josh GottheimerU.S. Congress Member (D-NJ)Buy$14.51$1,001 - $15,0007/10/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$13.55$1,001 - $15,0003/31/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$12.29$15,001 - $50,0002/27/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Buy$12.55$1,001 - $15,000 (Data available from 1/1/2013 forward) CHGCY Insider Trading Activity - Frequently Asked Questions Which members of congress are trading Chugai Pharmaceutical? Josh Gottheimer (D-NJ) has sold shares of Chugai Pharmaceutical in the last year totaling $16,000. Chugai Pharmaceutical Key ExecutivesDr. Osamu Okuda (Age 61)President, CEO & Chairman Compensation: $1.69MMr. Iwaaki Taniguchi (Age 57)Executive VP, Head of Finance Supervisory Division, CFO & Director Toshiya SasaiExecutive of Investor Relations Group & Corporate Communications DepartmentMr. Masayoshi HiguchiVP and Head of Quality, Regulatory Compliance Unit, Business Strategy & Compliance Dept.Junichi TakanoHead of Marketing & Sales DivisionMr. Shinji HidakaExecutive Vice PresidentMr. Junichi EbiharaExecutive Vice PresidentDr. Yoshiaki Ohashi (Age 64)Senior VP & Full-time Audit Supervisory Board Member Mr. Tetsuya YamaguchiExecutive VP & Head of PHC Solution UnitMr. Yoshiyuki YanoExecutive Vice President More Insider Trading Tools from MarketBeat Related Companies McKesson Insider Selling Cencora Insider Selling Cardinal Health Insider Selling Herbalife Insider Selling Nu Skin Enterprises Insider Selling Cosmos Health Insider Selling HWH International Insider Selling TRxADE HEALTH Insider Selling AbbVie Insider Selling Novo Nordisk A/S Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Meta's Institutional & Insider Data Fuels Bulls Despite DisparityTurbulence for Joby Shares: What's Behind the Recent Dip?UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals5 Hot Small-Cap Insiders Bought at the Peak of Tariff Fears This page (OTCMKTS:CHGCY) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chugai Pharmaceutical Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chugai Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CHGCY Stock Free CHGCY Stock Alerts